ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984

RRP Planning Dosimetry Center, Treatment Planning Projects

March 20, 1987

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

White House Estimates Automatic Budget Cuts Would Take 8.2 Percent From NCI, NIH and FDA

September 21, 2012

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988